References
- Ma B, Yang L, Jing R, Liu J, Quan Y, Hui Q, Li J, Qin L, Pei C. Effects of Interleukin −6 on posterior capsular opacification. Exp Eye Res. 2018 Jul;172: 94–103. doi:https://doi.org/10.1016/j.exer.2018.03.013.
- Nibourg LM, Gelens E, Kuijer R, Hooymans JM, van Kooten TG, Koopmans SA. Prevention of posterior capsular opacification. Exp Eye Res. 2015 Jul;136: 100–15. doi:https://doi.org/10.1016/j.exer.2015.03.011.
- Nam MH, Smith AJO, Pantcheva MB, Park KU, Brzezinski JA, Galligan JJ, Fritz K, Wormstone IM, Nagaraj RH. Aspirin inhibits TGF「2-induced epithelial to mesenchymal transition of lens epithelial cells: selective acetylation of K56 and K122 in histone H3. Biochem J. 2020 Jan 17;477(1): 75–97. doi:https://doi.org/10.1042/BCJ20190540.
- Hybiak J, Broniarek I, Kiryczynski G, Los LD, Rosik J, Machaj F, Slawinski H, Jankowska K, Urasinska E. Aspirin and its pleiotropic application. Eur J Pharmacol. 2020 Jan 5;866: 172762. doi:https://doi.org/10.1016/j.ejphar.2019.172762.
- Wormstone IM. The human capsular bag model of posterior capsule opacification. Eye (Lond). 2020 Feb;34(2): 225–31. doi:https://doi.org/10.1038/s41433-019-0680-z.
- Eldred JA, Zheng J, Chen S, Wormstone IM. An in vitro human lens capsular bag model adopting a graded culture regime to assess putative impact of IOLs on PCO formation. Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1): 113–22. doi:https://doi.org/10.1167/iovs.18-25930.
- Dawes LJ, Illingworth CD, Wormstone IM. A fully human in vitro capsular bag model to permit intraocular lens evaluation. Invest Ophthalmol Vis Sci. 2012 Jan 3;53(1): 23–29. doi:https://doi.org/10.1167/iovs.11-8851.
- Eldred JA, Spalton DJ, Wormstone IM. An in vitro evaluation of the Anew Zephyr open-bagIOL in the prevention of posterior capsule opacification using a human capsular bag model. Invest Ophthalmol Vis Sci. 2014;55(11): 7057–64. doi:https://doi.org/10.1167/iovs.14-15302.
- Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005 Feb 12-18;365(9459): 599–609. doi:https://doi.org/10.1016/S0140-6736(05)17911-2.
- Li J, Xue W, Wang X, Huang W, Wang XX, Li H, Cui X, Li M, Mu H, Ren Y, et al. HSP90 as a novel therapeutic target for posterior capsule opacification. Exp Eye Res. 2019 Dec;189: 107821. doi:https://doi.org/10.1016/j.exer.2019.107821.
- Lin L, Lin Q, Li J, Han Y, Chang P, Lu F, Zhao YE. ROCK inhibitor modified intraocular lens as an approach for inhibiting the proliferation and migration of lens epithelial cells and posterior capsule opacification. Biomater Sci. 2019 Sep 24;7(10): 4208–17. doi:https://doi.org/10.1039/c9bm00787c.
- McDonnell PJ, Stark WJ, Green WR. Posterior capsule opacification: a specular microscopic study. Ophthalmology. 1984 Jul;91(7): 853–56. doi:https://doi.org/10.1016/s0161-6420(84)34226-9.
- Dewey S. Posterior capsule opacification. Curr Opin Ophthalmol. 2006 Feb;17(1): 45–53. doi:https://doi.org/10.1097/01.icu.0000193074.24746.e6.
- Liu J, Xu D, Li J, Gao N, Liao C, Jing R, Wu B, Ma B, Shao Y, Pei C. The role of focal adhesion kinase in transforming growth factor-「2 induced migration of human lens epithelial cells. Int J Mol Med. 2018 Dec;42(6): 3591–601. doi:https://doi.org/10.3892/ijmm.2018.3912.
- Zukin LM, Pedler MG, Groman-Lupa S, Pantcheva M, Ammar DA, Petrash JM. Aldose reductase inhibition prevents development of posterior capsular opacification in an in vivo model of cataract surgery. Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8): 3591–98. doi:https://doi.org/10.1167/iovs.18-23935.
- Cammas L, Wolfe J, Choi SY, Dedhar S, Beggs HE. Integrin-linked kinase deletion in the developing lens leads to capsule rupture, impaired fiber migration and non-apoptotic epithelial cell death. Invest Ophthalmol Vis Sci. 2012 May 17;53(6):3067–81. doi:https://doi.org/10.1167/iovs.11-9128.
- Magri AMP, Fernandes KR, Assis L, Kido HW, Avanzi IR, Medeiros MDC, Granito RN, Braga FJC, Renno ACM. Incorporation of collagen and PLGA in bioactive glass: in vivo biological evaluation. IntJ Biol Macromol. 2019 Aug 1;134: 869–81. doi:https://doi.org/10.1016/j.ijbiomac.2019.05.090.
- Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z. Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda). 2017 Jul;32(4): 266–77. doi:https://doi.org/10.1152/physiol.00036.2016.
- Alhaque S, Themis M, Rashidi H. Three-dimensional cell culture: from evolution to revolution. Philos Trans R Soc Lond B Biol Sci. 2018 Jul 5;373(1750): 20170216. doi:https://doi.org/10.1098/rstb.2017.0216.
- McKee C, Chaudhry GR. Advances and challenges in stem cell culture. Colloids SurfB Biointerfaces. 2017 Nov1;159: 62–77. doi:https://doi.org/10.1016/j.colsurfb.2017.07.051.
- Harberts J, Fendler C, Teuber J, Siegmund M, Silva A, Rieck N, Wolpert M, Zierold R, Blick RH. Toward brain-on-a-chip: human induced pluripotent stem cell- derived guided neuronal networks in tailor-made 3D nanoprinted microscaffolds. ACS Nano. 2020 Oct 27;14(10): 13091–102. doi:https://doi.org/10.1021/acsnano.0c04640.
- Zujur D, Kanke K, Lichtler AC, Hojo H, Chung UI, Ohba S. Three-dimensional system enabling themaintenance and directed differentiation of pluripotent stem cells under defined conditions. Sci Adv. 2017 May 12;3(5): e1602875. doi:https://doi.org/10.1126/sciadv.1602875.
- Olejniczak-k^der A, Szarynska M, Wronska A, Siedlecka-Kroplewska K, Kmiec Z. Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system ofHCT116 and HT29 colorectal cancer cell lines. Int J Oncol. 2019 Jul;55(1): 223–42. doi:https://doi.org/10.3892/ijo.2019.4809.
- Yuan X, Zhou M, Gough J, Glidle A, Yin H. A novel culture system for modulating single cell geometry in 3D. Acta Biomater. 2015 Sep;24: 228–40. doi:https://doi.org/10.1016/j.actbio.2015.06.008.
- Kim K, Kim SH, Lee GH, Park JY. Fabrication of omega-shaped microwell arrays for a spheroid culture platform using pins of a commercial CPU to minimize cell loss and crosstalk. Biofabrication. 2018 Aug 14;10(4): 045003. doi:https://doi.org/10.1088/1758-5090/aad7d3.
- Jun JH, Sohn WJ, Lee Y, Chang SD, Kim JY. Experimental lens capsular bag model for posterior capsule opacification. Cell Tissue Res. 2014 Jul;357(1): 101–08. doi:https://doi.org/10.1007/s00441-014-1870-4.
- Ryan EJ, Ryan AJ, Gonzalez-Vazquez A, Philippart A, Ciraldo FE, Hobbs C, Nicolosi V, Boccaccini AR, Kearney CJ, O’Brien FJ. Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo. Biomaterials. 2019 Mar;197: 405–16. doi:https://doi.org/10.1016/j.biomaterials.2019.01.031.
- Barza M, Kane A, Baum J. Comparison of the effects of continuous and intermittent systemic administration on the penetration of gentamicin into infected rabbit eyes. J Infect Dis. 1983 Jan;147(1): 144–48. doi:https://doi.org/10.1093/infdis/147.1.144.
- Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell PJ. Perioperative antibioticsfor prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017 Feb 13;2(2): CD006364. doi:https://doi.org/10.1002/14651858.CD006364.pub3.
- Wertheimer C, Kassumeh S, Piravej NP, Nilmayer O, Braun C, Priglinger C, Luft N, Wolf A, Mayer WJ, Priglinger SG, et al. The intraocular lens as a drug delivery device: in vitro screening of pharmacologic substances for the prophylaxis of posterior capsule opacification. Invest OphthalmolVis Sci. 2017 Dec 1;58(14): 6408–18. doi:https://doi.org/10.1167/iovs.17-22555.
- Vieira AP, Pimenta AFR, Silva D, Gil MH, Alves P, Coimbra P, Mata JLGC, Bozukova D, Correia TR, Correia IJ, et al. Surface modification of an intraocular lens material by plasma-assisted grafting with 2- hydroxyethyl methacrylate (HEMA), for controlled release of moxifloxacin. Eur J Pharm Biopharm. 2017 Nov;120: 52–62. https://doi.org/10.1016/j.22555.
- Topete A, Oliveira AS, Fernandes A, Nunes TG, Serro AP, Saramago B. Improving sustained drug delivery from ophthalmic lens materials through the control of temperature and time ofloading. Eur J Pharm Sci. 2018 May 30;117: 107–17. https://doi.org/10.1016/j.22555.
- Dogan C, Yetik H, Arslan OS, Seymen HO, Suzer O, Aydin O, Mergen B. The safety of intraocular usage of aspirin. Cutan Ocul Toxicol. 2019 Jun;38(2): 201–05. doi:https://doi.org/10.1080/15569527.2019.1575391.
- Wang L, Mai Z, Zhao M, Wang B, Yu S, Wang X, Chen T. Aspirin induces oncosis in tumor cells. Apoptosis. 2019 Oct;24(9–10): 758–72. doi:https://doi.org/10.1007/s10495-019-01555-7.
- Pan MR, Chang HC, Hung WC. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal. 2008 Jun;20(6): 1134–41. doi:https://doi.org/10.1016/j.cellsig.2008.02.004.
- Dawes LJ, Shelley EJ, McAvoy JW, Lovicu FJ. A role for Hippo/YAP-signaling in FGF-induced lens epithelial cell proliferation and fibre differentiation. Exp Eye Res. 2018 Apr;169: pp. 122–33. doi:https://doi.org/10.1016/j.exer.2018.01.014.
- Gonzalez-Chomon C, Braga ME, de Sousa HC, Concheiro A, Alvarez-Lorenzo C. Antifouling foldable acrylic IOLs loaded with norfloxacin by aqueous soaking and by supercritical carbon dioxide technology. Eur J Pharm Biopharm. 2012 Oct;82(2): 383–91. https://doi.org/10.1016/j225.55.
- Cortellini G, Caruso C, Romano A. Aspirin challenge and desensitization: how, when and why. CurrOpin Allergy Clin Immunol. 2017 Aug;17(4): 247–54. doi:https://doi.org/10.1097/ACI.0000000000000374.
- Hua H, Zhang H, Kong Q, Wang J, Jiang Y. Complex roles of the old drug aspirin In cancer chemoprevention and therapy. Med Res Rev. 2019 Jan;39(1): 114–45. doi:https://doi.org/10.1002/med.21514.
- Patel NJ, Baliga RR. Role of Aspirin for primary prevention in persons with diabetes mellitusand in the elderly. Curr Cardiol Rep. 2020 May 29;22(7): 48. doi:https://doi.org/10.1007/s11886-020-01296-z.
- Zhang X, Feng Y, Liu X, Ma J, Li Y, Wang T, Li X. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer. J Cancer Res Clin Oncol. 2019 Jun;145(6): 1387–403. doi:https://doi.org/10.1007/s00432-019-02902-6.
- Haykal T, Barbarawi M, Zayed Y, Yelangi A, Dhillon H, Goranta S, Kheiri B, Chahine A, Samji V, Kerbage J, et al. Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials. J Cancer Res Clin Oncol. 2019 Jul;145(7): 1795–809. doi:https://doi.org/10.1007/s00432-019-02932-0.
- Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012 Jun;23(6): 1403–15. doi:https://doi.org/10.1093/annonc/mds113.